符合混合植入系统候选标准的低频听力损失自然进展
该回顾性数据库研究纳入944例患者共1083耳的听力图,分析符合混合人工耳蜗候选标准者的低频残余听力进展。所有病因平均进展为1.70±0.10 dB/年;梅尼埃病(5.0±0.93 dB/年)和自身免疫性疾病(3.5±0.76 dB/年)进展显著更快,陡降型听力损失同侧耳进展也更快。
要点
- 梅尼埃病和自身免疫性内耳病是低频残余听力快速进展的风险因素。
- 陡降型听力损失患者同侧耳进展显著快于其他听力学类型。
- 特发性、遗传性及先天性听力损失进展为1.46±0.10 dB/年。
核心结论
- 梅尼埃病、自身免疫介导的内耳疾病及同侧耳陡降型听力损失是低频残余听力更快进展的风险因素。
研究设计与样本
- 回顾性数据库研究,纳入944例患者共1083耳,排除耳蜗后病因、年龄<6岁、观察时间<1年及混合性或传导性听力损失者。
主要发现
- 所有病因在250 Hz、500 Hz和1 kHz平均听阈的年进展为1.70±0.10 dB/年。
- 梅尼埃病患者进展为5.0±0.93 dB/年,自身免疫性疾病患者为3.5±0.76 dB/年,均显著快于其他病因。
- 特发性、遗传/遗传性及先天性听力损失患者进展为1.46±0.10 dB/年。
- 陡降型听力损失患者同侧耳进展显著快于其他听力学类型。
关键数值与推荐
- 研究未报告混合人工耳蜗候选的具体听力学阈值标准。
临床怎么用
- 对符合混合人工耳蜗候选标准者,应关注梅尼埃病、自身免疫性内耳病及陡降型听力损失,因其低频残余听力进展更快。
局限性
- 证据等级为4级。
- 研究为回顾性数据库分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To investigate the natural progression of hearing loss in patients with high-frequency hearing loss whose audiograms met the criteria for a hybrid cochlear implant (CI). STUDY DESIGN: Retrospective database review. METHODS: We retrospectively identified patients who met the criteria for a hybrid CI from our audiometric database. We also recorded the etiology of hearing loss in each patient and excluded patients with retrocochlear etiologies, those age <6 years, duration of observation <1 year, or those with a mixed or conductive hearing loss. We calculated the pre-CI progression of residual low-frequency (LF) hearing level in decibels per year and investigated the risk factor of the progression of hearing loss. RESULTS: A total of 1,083 ears of 944 patients were included in this study. The average rate of hearing loss progression for all etiologies was 1.70 ± 0.10 dB/yr at an average of 250 Hz, 500 Hz, and 1 kHz in the affected ear(s). The progression of hearing loss was 5.0 ± 0.93 dB/yr in patients with Meniere's disease and 3.5 ± 0.76 dB/yr in those with autoimmune disease, both of which were significantly faster than progression rates in other etiologies. In patients with idiopathic, genetic/hereditary, and congenital hearing loss, the progression of hearing loss was 1.46 ± 0.10 dB/yr. Patients with steeply sloping hearing loss experienced significantly faster progression in the ipsilateral ear compared to patients with another audiometric type. CONCLUSIONS: It is suggested that Meniere's disease, autoimmune-mediated inner ear disease, and steeply sloping hearing loss in the ipsilateral ear are risk factors for faster progression of residual LF hearing level. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:1299-1303, 2020.
引用
- Okada M, Quinkert A, Franck KH, et al. The natural progression of low-frequency hearing loss in patients who meet hybrid implant system candidacy criteria. Laryngoscope. 2019. PMID: 31393603. doi:10.1002/lary.28217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。